1. Home
  2. BNTX
  3. BNTX News

Latest BioNTech SE (BNTX) News on July 27, 2024

BNTX

MT Newswires

2 days ago

Pfizer, BioNTech Covid Vaccine Receives Approval in UK

Triastek and BioNTech to develop 3D-printed RNA therapeutics
BNTX

Pharmaceutical Technology

3 days ago

Triastek and BioNTech to develop 3D-printed RNA therapeutics

BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
BNTX

GlobeNewswire

5 days ago

BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024

BNTX

MT Newswires

16 days ago

CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech

BNTX

MT Newswires

24 days ago

Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling

Lab to jab in 100 days: manufacturing flexibility for future rapid responses
BNTX

Pharmaceutical Technology

25 days ago

Lab to jab in 100 days: manufacturing flexibility for future rapid responses

Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
BNTX

Zacks

a month ago

Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod

CHMP recommends authorisation for Pfizer-BioNTech’s Covid-19 vaccine
BNTX

Pharmaceutical Technology

a month ago

CHMP recommends authorisation for Pfizer-BioNTech’s Covid-19 vaccine

BNTX

MT Newswires

a month ago

Pfizer, BioNTech Get Positive Committee Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in European Union

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
BNTX

Business Wire

a month ago

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

BNTX

MT Newswires

a month ago

BioNTech, Duality Biologics Receive FDA Fast-Track Designation for Prostate Cancer Drug

BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer
BNTX

GlobeNewswire

a month ago

BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer

FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
BNTX

Clinical Trials Arena

a month ago

FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
BNTX

Benzinga

a month ago

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment

BNTX

MT Newswires

a month ago

Sector Update: Health Care Stocks Ease in Afternoon Trading

BNTX

MT Newswires

a month ago

Top Midday Stories: Nvidia Gets SCOTUS Review of Crypto Sales Lawsuit; Apple Supplier Develops Material for Solid-State Batteries; OpenAI Reportedly Launches Medical AI Tool; Walt Disney's 'Inside Out 2' Sets Biggest Opening of 2024; IQVentures to Acquire Aaron's

BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
BNTX

Bloomberg

a month ago

BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay

BNTX

MT Newswires

a month ago

BioNTech Says US FDA Placed Partial Clinical Hold on Cancer Drug Trial

FDA considers updating COVID boosters, Novavax stock reacts
BNTX

Yahoo Finance Video

2 months ago

FDA considers updating COVID boosters, Novavax stock reacts

Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
BNTX

Clinical Trials Arena

2 months ago

Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
BNTX

Business Wire

2 months ago

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)

NHS launches personalised mRNA cancer vaccines trial
BNTX

Clinical Trials Arena

2 months ago

NHS launches personalised mRNA cancer vaccines trial

BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities
BNTX

Pharmaceutical Technology

2 months ago

BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities

BNTX

MT Newswires

2 months ago

BioNTech, CEPI Expand Partnership for mRNA Vaccine Ecosystem in Africa

BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
BNTX

GlobeNewswire

2 months ago

BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem

BNTX

MT Newswires

2 months ago

BioNTech Collaborating with MediLink to Develop More Potential Antibody-Drug Conjugate, Immunotherapy Treatments

MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
BNTX

PR Newswire

2 months ago

MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership

Why Vaccine Stocks Rallied This Week
BNTX

Motley Fool

2 months ago

Why Vaccine Stocks Rallied This Week

BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
BNTX

GlobeNewswire

2 months ago

BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024

BNTX

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Autolus Therapeutics PLC Earnings Call

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
BNTX

Benzinga

2 months ago

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

BNTX

MT Newswires

2 months ago

Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech

BNTX

MT Newswires

2 months ago

Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
BNTX

GlobeNewswire

2 months ago

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024

BNTX

MT Newswires

2 months ago

Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target

We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
BNTX

Simply Wall St.

3 months ago

We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
BNTX

Simply Wall St.

3 months ago

BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
BNTX

Insider Monkey

3 months ago

BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript

BioNTech reports net loss of €315.1m in Q1 2024
BNTX

Pharmaceutical Technology

3 months ago

BioNTech reports net loss of €315.1m in Q1 2024

BNTX

Thomson Reuters StreetEvents

3 months ago

Q1 2024 BioNTech SE Earnings Call

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
BNTX

Investor's Business Daily

3 months ago

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come

BNTX

Morningstar Research

3 months ago

Analyst Report: BioNTech SE

BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
BNTX

Motley Fool

3 months ago

BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript

BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline
BNTX

MT Newswires

3 months ago

BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline

What's Going With BioNTech Stock On Monday?
BNTX

Benzinga

3 months ago

What's Going With BioNTech Stock On Monday?

BioNTech Slides After Reporting Losses As Covid Vaccine Sales Take A Hit
BNTX

Investor's Business Daily

3 months ago

BioNTech Slides After Reporting Losses As Covid Vaccine Sales Take A Hit

BNTX

MT Newswires

3 months ago

Sector Update: Health Care

BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
BNTX

Barrons.com

3 months ago

BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales

BNTX

MT Newswires

3 months ago

BioNTech Swings to Q1 Loss, Revenue Falls -- Shares Decline Pre-Bell

BNTX

Reuters

3 months ago

UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year

BNTX

Reuters

3 months ago

BioNTech says 90% of 2024 revenues will accrue at end of year

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
BNTX

GlobeNewswire

3 months ago

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update

Why Earnings Season Could Be Great for BioNTech (BNTX)
BNTX

Zacks

3 months ago

Why Earnings Season Could Be Great for BioNTech (BNTX)

BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
BNTX

Zacks

3 months ago

BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?

BNTX

MT Newswires

3 months ago

Sector Update: Health Care Stocks Drop in Afternoon Trading

Wall Street plunges after US inflation shock
BNTX

The Telegraph

3 months ago

Wall Street plunges after US inflation shock

BNTX

MT Newswires

3 months ago

Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines

BNTX

MT Newswires

3 months ago

GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines

BNTX

Reuters

3 months ago

UPDATE 1-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
BNTX

Reuters

3 months ago

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

Pfizer vs Moderna battle over COVID vaccine patents begins in UK
BNTX

Reuters

3 months ago

Pfizer vs Moderna battle over COVID vaccine patents begins in UK

25 Richest Billionaires in Healthcare Industry
BNTX

Insider Monkey

3 months ago

25 Richest Billionaires in Healthcare Industry

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
BNTX

GlobeNewswire

3 months ago

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
BNTX

GlobeNewswire

4 months ago

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value
BNTX

Barrons.com

4 months ago

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value

BNTX

Reuters

4 months ago

UPDATE 2-BioNTech gets US agency notice over default on COVID vaccine royalties

BNTX

Reuters

4 months ago

BioNTech gets notice from NIH on default on royalties

BioNTech Full Year 2023 Earnings: Misses Expectations
BNTX

Simply Wall St.

4 months ago

BioNTech Full Year 2023 Earnings: Misses Expectations

Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts
BNTX

Simply Wall St.

4 months ago

Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts

BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript
BNTX

Insider Monkey

4 months ago

BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript

BNTX

Thomson Reuters StreetEvents

4 months ago

Q4 2023 BioNTech SE Earnings Call

BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
BNTX

Investor's Business Daily

4 months ago

BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts

BNTX

Morningstar Research

4 months ago

Analyst Report: BioNTech SE

BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
BNTX

Benzinga

4 months ago

BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials

BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
BNTX

Motley Fool

4 months ago

BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript

BNTX

Reuters

4 months ago

BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline

BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower.
BNTX

Barrons.com

4 months ago

BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower.

BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts
BNTX

Investor's Business Daily

4 months ago

BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts

BioNTech Earnings Fall Short of Estimates. The Stock Is Down.
BNTX

Barrons.com

4 months ago

BioNTech Earnings Fall Short of Estimates. The Stock Is Down.

BNTX

Reuters

4 months ago

UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches

After earnings plunge, BioNTech pins hopes on cancer drug launches
BNTX

Reuters

4 months ago

After earnings plunge, BioNTech pins hopes on cancer drug launches

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
BNTX

GlobeNewswire

4 months ago

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
BNTX

GlobeNewswire

4 months ago

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript
BNTX

Insider Monkey

4 months ago

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript

BNTX

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Autolus Therapeutics PLC Earnings Call

BNTX

GuruFocus.com

4 months ago

Autolus Therapeutics PLC Reports Full Year 2023 Financial Results

Moderna, BioNTech Stocks Rise on New mRNA Possibilities
BNTX

The Wall Street Journal

5 months ago

Moderna, BioNTech Stocks Rise on New mRNA Possibilities

Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
BNTX

Simply Wall St.

5 months ago

Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?

BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
BNTX

GlobeNewswire

5 months ago

BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
BNTX

Insider Monkey

5 months ago

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

Here’s Why Artisan Mid Cap Fund Harvested BioNTech SE (BNTX)
BNTX

Insider Monkey

5 months ago

Here’s Why Artisan Mid Cap Fund Harvested BioNTech SE (BNTX)

BioNTech Announces Planned Retirement of Sean Marett
BNTX

GlobeNewswire

5 months ago

BioNTech Announces Planned Retirement of Sean Marett

3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
BNTX

InvestorPlace

5 months ago

3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success

BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
BNTX

GlobeNewswire

5 months ago

BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024

Here’s Why BioNTech SE (BNTX) Declined 12.2% in Q4
BNTX

Insider Monkey

5 months ago

Here’s Why BioNTech SE (BNTX) Declined 12.2% in Q4

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
BNTX

InvestorPlace

5 months ago

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound

It’s Time! 3 Dodgy Pharma Stocks to Sell in February
BNTX

InvestorPlace

5 months ago

It’s Time! 3 Dodgy Pharma Stocks to Sell in February

BioNTech SE's (NASDAQ:BNTX) largest shareholders are private equity firms with 44% ownership, insiders own 20%
BNTX

Simply Wall St.

5 months ago

BioNTech SE's (NASDAQ:BNTX) largest shareholders are private equity firms with 44% ownership, insiders own 20%

BioNTech partners with Autolus to boost cell therapy manufacturing
BNTX

BioPharma Dive

6 months ago

BioNTech partners with Autolus to boost cell therapy manufacturing

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
BNTX

GlobeNewswire

6 months ago

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

Share on Social Networks: